• Arcturus Therapeutics Appoints Interim CFO contractpharma
    August 29, 2018
    Arcturus Therapeutics has appointed Andrew Sassine as Interim chief financial officer, effective August 24, 2018. Mr. Sassine has served on Arcturus’ Board of Directors since May 2018 and will continue to serve on Arcturus’ Board of Directors.
PharmaSources Customer Service